ArticleApplied microbiology and biotechnology2025
Identification and functional characterization of a novel thioredoxin MpTRX1 from Metschnikowia persimmonesis.
Article in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thioredoxins (TRXs) are small, conserved redox-active proteins that play central roles in oxidative stress responses. Here, we identified and functionally characterized a novel thioredoxin, MpTRX1, from the newly isolated yeast Metschnikowia persimmonesis. The full-length MpTRX1 gene was cloned and expressed in Escherichia coli and Saccharomyces cerevisiae to analyze its biochemical and physiological functions. MpTRX1 encodes a 103-amino-acid protein containing a canonical CXXC redox motif, and structural modeling confirmed a conserved thioredoxin fold. Recombinant MpTRX1 exhibited clear disulfide reductase activity in both DTNB (5,5'-dithiobis-(2-nitrobenzoic acid)) and insulin reduction assays. Mutation of either catalytic cysteine residue abolished activity, confirming their essential roles. Moreover, heterologous expression of MpTRX1 in S. cerevisiae enhanced tolerance to hydrogen-peroxide-induced oxidative stress. Although the functional assays were conducted in a heterologous system, these findings demonstrate that MpTRX1 is a bona fide thioredoxin that may contribute to oxidative stress protection in M. persimmonesis. This work provides the first molecular characterization of a protein from M. persimmonesis and establishes a foundation for future studies on its potential ecological and biotechnological applications. KEY POINTS: • Identification of MpTRX1, a novel thioredoxin from M. persimmonesis. • Recombinant MpTRX1 reduces both chemical and protein substrates. • Overexpression of MpTRX1 enhances oxidative stress tolerance in S. cerevisiae.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.